Developing and Testing of an Upper Limb
Exoskeleton for Stroke Patients
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Purpose: To determine the functional outcomes of stroke patients using their nonpreferred hand with and without a 3D printed passive exoskeleton compared to
controls.
Hypothesis: The exoskeleton will increase the function of the stroke patient’s
affected hand and the usability questionnaire scores will be associated with
improvement in the functional test results.

METHODS
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RESULTS

INTRODUCTION
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Stroke has a large impact on disability and loss of motor function[1]. It can cause
the affected upper limb to become spastic with a predominantly flexor tone. Stroke
patients have shown improvements in hand mobility through sensorimotor arm
therapy[2]. However, therapy can be expensive, and many patients still lack
function in their affected hand when rehabilitation is finished[3]. Wearable devices,
such as exoskeletons are useful in that they offer the ability for patients to regain
mobility in their own environment[2]. The upper limb exoskeletons are designed to
interact independently with the user while assisting and promoting movement of
the affected hand. Our inexpensive and simple exoskeleton design is produced on
a low-cost 3D printer, and allows for patients to have access outside of the lab. It is
important for this exoskeleton to not only be easily accessible, but effective and
useful. Traditional definitions of usability incorporate effectiveness, efficiency, and
satisfaction of the user with the product. In the context of stroke survivors, the
exoskeleton should be able to assist the user in extending their affected hand and
allowing for flexion to grasp an object.
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FIGURE 1. The differences for stroke patients in not-using the exoskeleton with their nonpreferred hand (left) compared to using the exoskeleton with their non-preferred hand
(right)
• For the Box and Block test (Figure 1) there was an interaction [F(1,4) = 41.60; p =
.003, ηp2 = 0.912] with an observed power of 0.996
• Decomposing the model, a dependent t-test (p = 0.004) showed the stroke
subject’s preferred hand moved more blocks than the stroke subject’s nonpreferred hand
• The exoskeleton received an average QUEST score of 4.23
0.26 out of a
maximum score of 5 and SUS score of 79.50
15.45 out of 100

DISCUSSION
•
•
•

Subjects:
• 5 participants with stroke with impairments at least 6-months post stroke
• 5 age and sex matched healthy controls
Procedure:
• Exoskeleton devices were custom scaled and fitted to each subject with stroke
• Three box and block trials were each performed with the preferred hand, nonpreferred hand, and non-preferred hand with the exoskeleton
• Two usability questionnaires, the System Usability Scale (SUS) and the
Quebec User Evaluation of Satisfaction with assistive Technology (QUEST),
were given to the subjects after testing of the exoskeleton
• Separate two-way repeated measures ANOVAs [2 x 2; exoskeleton (with
versus without exoskeleton) x group (stroke versus control)] were performed to
analyze the effects of using an exoskeleton in stroke and control groups
• A p-value of ≤ 0.05 was considered statistically significant for all comparisons

The mean showed no improvement in function with the exoskeleton, but two
subjects were able to increase functional improvement with the exoskeleton
While the exoskeleton did not help with performance, the overall usability scores
it received can be interpreted as “good” and “quite satisfied”
This was the first time the subjects used the exoskeleton and a follow-up study
would be beneficial to evaluate if any learning effects occurred

CONCLUSION
The present study showed that the passive exoskeleton developed did not improve
function for the stroke patients. However, the exoskeleton was able to assist two of
the five subjects. Due to the differences and variation seen in impairments with
stroke, the exoskeleton has shown it can be useful in individual cases.
Future Work: The exoskeleton will continue to be tested on new subjects and
evaluating how stroke subjects’ functional performance changes through prolonged
use with the exoskeleton will be tested as well.
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